195 related articles for article (PubMed ID: 11530809)
1. Waldenström's macroglobulinemia associated with AA amyloidosis.
Gardyn J; Schwartz A; Gal R; Lewinski U; Kristt D; Cohen AM
Int J Hematol; 2001 Jul; 74(1):76-8. PubMed ID: 11530809
[TBL] [Abstract][Full Text] [Related]
2. Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplant.
Muzaffar J; Katragadda L; Haider S; Abdallah AO; Anaissie E; Usmani SZ
Acta Haematol; 2013; 130(3):146-9. PubMed ID: 23689541
[TBL] [Abstract][Full Text] [Related]
3. Report of Consensus Panel 6 from the 11 th International Workshop on Waldenström's Macroglobulinemia on Management of Waldenström's Macroglobulinemia Related Amyloidosis.
Merlini G; Sarosiek S; Benevolo G; Cao X; Dimopoulos M; Garcia-Sanz R; Gatt ME; Fernandez de Larrea C; San-Miguel J; Treon SP; Minnema MC
Semin Hematol; 2023 Mar; 60(2):113-117. PubMed ID: 37099030
[TBL] [Abstract][Full Text] [Related]
4. An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis.
Møyner K; Sletten K; Husby G; Natvig JB
Scand J Immunol; 1980; 11(5):549-54. PubMed ID: 6155694
[TBL] [Abstract][Full Text] [Related]
5. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
Gertz MA; Kyle RA; Noel P
J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
[TBL] [Abstract][Full Text] [Related]
6. [Check-valve-mechanism in Waldenstrom's macroglobulinemia with pericollagen amyloidosis].
Missmahl HP; Gelinsky P; Braun HJ; Dold U
Med Welt; 1969 Jan; 1():39-41. PubMed ID: 4975603
[No Abstract] [Full Text] [Related]
7. Combined Waldenström's macroglobulinaemia associated AL and beta-2-microglobulin amyloidosis.
Jones CH; Kanagasundaram NS; Coral AP; Coyne JD; Will EJ
Nephrol Dial Transplant; 1997 Dec; 12(12):2708-12. PubMed ID: 9430877
[No Abstract] [Full Text] [Related]
8. [General AL-amyloidosis: a rare complication in Waldenstrom macroglobulinemia].
Zimmermann I; Gloor HJ; Rüttimann S
Praxis (Bern 1994); 2001 Nov; 90(47):2050-5. PubMed ID: 11763619
[TBL] [Abstract][Full Text] [Related]
9. [Amyloid cardiopathy disclosing Waldenström's macroglobulinemia].
Rego J; Adoue D; Couret B; Arlet-Suau E; Fedou R; Chamontin B
Presse Med; 1983 Nov; 12(39):2464. PubMed ID: 6227898
[No Abstract] [Full Text] [Related]
10. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects].
Lovisetto P; Frascisco M; Gilardi E; Marchi L; Mairano D
Minerva Med; 1980 Jun; 71(25):1801-13. PubMed ID: 6774298
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinemia associated with amyloidosis and crescentic glomerulonephritis.
Ogami Y; Takasugi M; Soejima M; Kuroiwa A; Oma H; Nakano M; Haratake J; Toyoshima M; Watanabe T
Nephron; 1989; 51(1):95-8. PubMed ID: 2492644
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of different amyloid fibril proteins in tissue sections.
Cornwell GG; Husby G; Westermark P; Natvig JB; Michaelsen TE; Skogen B
Scand J Immunol; 1977; 6(11):1071-80. PubMed ID: 413186
[TBL] [Abstract][Full Text] [Related]
13. Waldenström's macroglobulinemia associated with amyloidosis and membranous nephropathy.
Muso E; Tamura I; Yashiro M; Asaka Y; Kataoka Y; Nagai H; Takahashi T
Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1265-9. PubMed ID: 8139140
[TBL] [Abstract][Full Text] [Related]
14. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
Bély M; Apáthy A
Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
[TBL] [Abstract][Full Text] [Related]
15. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
van Rijswijk MH; van Heusden CW
Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneal amyloidosis in Waldenström's macroglobulinemia].
Raffi F; Cerbelaud P; Lerat F; Cuillière P; Rymer R; Le Bodic L
Gastroenterol Clin Biol; 1985 Dec; 9(12):950-1. PubMed ID: 3938421
[No Abstract] [Full Text] [Related]
17. Waldenström's macroglobulinemia accompanying systemic amyloidosis: the usefulness of endobronchial ultrasound-guided transbronchial needle aspiration for detecting amyloid deposits.
Ishiguro T; Takayanagi N; Katoh N; Shimizu Y; Hoshi T; Yanagisawa T; Sugita Y
Intern Med; 2014; 53(24):2789-93. PubMed ID: 25500440
[TBL] [Abstract][Full Text] [Related]
18. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
Löfberg H; Thysell H; Westman K; Larsen S; Brun C; Gruic V; Grubb A
Acta Pathol Microbiol Immunol Scand A; 1987 Nov; 95(6):357-63. PubMed ID: 3120491
[TBL] [Abstract][Full Text] [Related]
19. Waldenström's macroglobulinemia with pulmonary amyloidosis.
Zatloukal P; Bezdícek P; Schimonová M; Havlícek F; Tesarová P; Slováková A
Respiration; 1998; 65(5):414-6. PubMed ID: 9782228
[TBL] [Abstract][Full Text] [Related]
20. Nonamyloidotic nephrotic syndrome in Waldenström's macroglobulinemia.
Tsuji M; Ochiai S; Taka T; Hishitani Y; Nagareda T; Mori H
Nephron; 1990; 54(2):176-8. PubMed ID: 2107454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
